9
Views
4
CrossRef citations to date
0
Altmetric
Research Article

No influence of hemochromatosis-related gene mutations on restenosis rate in a retrospective study of 137 patients after coronary stent implantation

, , , , , , & show all
Pages 181-186 | Published online: 10 Jul 2009

  • Holmes DR Jr, Vlietstra RE, Smith HC et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart. Lung and Blood Institute. Am J Cardiol 1984; 53: 77C-81C.
  • Ribichini F, Steffenino G, Dellavalle A et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998; 97: 147-154.
  • Amant C, Banters C, Bodart JC et al. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 1997; 96: 56-60.
  • Koch W, Kastrati A, Mehilli J et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 2000; 102: 197-202.
  • Roest M, van der Schouw YT, de VaIk B et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999; 100: 1268-1273.
  • Tuomainen TP, Kontula K, Nyyssonen K et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation 1999; 100: 1274-1279.
  • Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
  • Sullivan JL. Iron and sex differences in heart disease risk. Lancet 1981; 1: 1293-1294.
  • Salonen JT, Nyyssonen K, Korpela H et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-811.
  • Regnstrom J, Tornvall P, Kallner A et al. Stored iron levels and myocardial infarction at young age. Atherosclerosis 1994; 106: 123-125.
  • Baynes KD. Assessment of iron status. Clin Biochem 1996; 29: 209-215.
  • de Jaegere P, Mudra H, Figulla H et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographie results from the Multicenter Ultrasound Stenting in Coronaries Study. Fur Heart J 1998; 19: 1214-1223.
  • Mudra H, diMario C, deJaegere P et al. Randomized Comparison of Coronary Stent Implantation Under Ultrasound or Angiographie Guidance to Reduce Stent Restenosis (OPTlCUS Study). Circulation 2001; 104: 1343-1349.
  • SchU+00E4chinger V, Zeiher AM. Quantitative assessment of coronary vasoreactivity in humans in vivo. Circulation 1995; 92: 2087-2094.
  • Zeiher AM, Drexler H, WollschlU+00E4ger H et al. Modulation of coronary vasomotor tone: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
  • Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al. Geography of HFE C282Y and H63D mutations. Genet Test 2000; 4: 183-198.
  • Mercier G, Bathelier C, Lucotte G. Frequency of the C282Y mutation of hemochromatosis in five French populations. Blood Cells Mol Dis 1998; 24: 165-166.
  • Franco RF, Zago MA, Trip MD et al. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease. Br J Haematol 1998; 102: 1172-1175.
  • Calado RT, Franco RF, Pazin-Filho A et al. HFE gene mutations in coronary atherothrombotic disease. Braz J Med Biol Res 2000; 33: 301-306.
  • Schwartz RS, Huber KC, Murphy JG et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-274.
  • Hanke H, Kamenz J, Hassenstein S et al. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 1995; 16: 785-793.
  • de VaIk B, Witlox RS, van der Schouw YT et al. Biochemical expression of heterozygous hereditary hemochromatosis. Eur J Intern Med 2000; 11: 317-321.
  • Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984; 74: 1890-1894.
  • Yuan XM, Brunk UT, Olsson AG. Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vase Biol 1995; 15: 1345-1351.
  • Tzong-Shyuan Lee, Ming-Shi Shiao, Ching-Chien Pan et al. Iron-Deficient Diet Reduces Atherosclerotic Lesions in Apo E-Deficient Mice. Circulation 1999; 99: 1222-1229.
  • Li W, Yuan XM, Brunk UT. OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radie Res 1998; 29: 389-398.
  • Smith C, Mitchinson MJ, Aruoma Ol et al. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992; 286: 901-905.
  • Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495.
  • Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
  • Hoffmann R, Mintz GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
  • Serruys PW, Kay IP, Disco C et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol 1999; 34: 1067-1074.
  • Nassar BA, Zayed EM, Title EM et al. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. Can J Cardiol 1998; 14: 215-220.
  • Rossi E, McQuillan BM, Hung J et al. Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population. Stroke 2000; 31: 3015-3020.
  • de Feyter PJ, Kay P, Disco C et al. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999; 100: 1777-1783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.